What is a normal ejection fraction (EF) during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Ejection Fraction During Pregnancy

A normal ejection fraction during pregnancy ranges from 50% to 70%, which is the same as in non-pregnant women. 1

Cardiac Physiological Changes During Pregnancy

  • Cardiac output increases by 30-50% during pregnancy due to increased stroke volume and an elevated maternal heart rate (15-20 bpm above pre-pregnancy values) 2, 3
  • Heart rate typically increases to 80-95 beats per minute during early second trimester pregnancy 2
  • Systemic vascular resistance decreases due to endogenous vasodilators, leading to decreased mean arterial pressure that reaches its lowest point in the second trimester 2, 3
  • Despite these significant hemodynamic changes, the normal range for ejection fraction remains 50-70% during pregnancy 1, 4

Clinical Significance of Ejection Fraction During Pregnancy

  • An ejection fraction below 40% is considered reduced and represents a predictor of maternal cardiovascular events during pregnancy 1
  • Women with ejection fraction <40% should be counseled against pregnancy due to increased risk of complications 1
  • Studies show that women who develop peripartum cardiomyopathy maintain normal ejection fraction during gestation before the disease manifests, with PPCM defined as heart failure with ejection fraction <45% 5, 6
  • More sensitive measures like global longitudinal strain and global circumferential strain may detect early cardiac dysfunction before ejection fraction changes become apparent 6

Risk Assessment Based on Ejection Fraction

  • The CARPREG risk score identifies reduced systemic ventricular systolic function (ejection fraction <40%) as a predictor of maternal cardiovascular events 1
  • According to the modified WHO risk classification, important ventricular dysfunction (EF <40%) places women in a high-risk category for pregnancy complications 1
  • Women with ejection fraction ≤30% have significantly worse fetal and neonatal outcomes compared to those with ejection fraction >30%, with lower rates of live births (59% vs 90%) 7

Monitoring Recommendations

  • Women with normal ejection fraction (50-70%) generally require standard prenatal cardiac monitoring 1, 4
  • Those with borderline or mildly reduced ejection fraction (40-49%) require more frequent monitoring during pregnancy 1
  • Women with ejection fraction <40% should have frequent echocardiographic surveillance (every 4-8 weeks) to assess for deterioration in cardiac function 1
  • Position changes can significantly affect cardiac measurements - the left lateral position is preferred over the supine position, especially after 20 weeks gestation 2, 3

Common Pitfalls in Assessment

  • Ejection fraction measurements can vary between imaging modalities and methods (visual vs. quantitative) 1
  • When reported as a numerical value, the imaging modality and method of analysis should be specified 1
  • Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized during pregnancy and may be missed if focusing solely on ejection fraction 8
  • Strain imaging may detect subclinical dysfunction in women with normal ejection fraction who later develop peripartum cardiomyopathy 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Normal Resting Heart Rate in Early Second Trimester Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Heart Rate Variability Changes During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluid Administration Guidelines for Post-PTCA Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.